- Telehealth Visits
- Insurance plan information
Kati L. Malabed, MS
- Telehealth Visits
- Insurance plan information
Prenatal Diagnostic Testing Greenbrae
Kati L. Malabed, MS
Prenatal Diagnostic Testing Greenbrae
- Telehealth Visits
- Insurance plan information
On this page
About me
Kati Malabed is a genetic counselor who specializes in prenatal diagnostic testing.
Malabed earned a bachelor's degree in biology at Trinity College. She earned her master's degree in genetic counseling at the University of California, Berkeley School of Public Health.
Malabed joined UCSF in 1996. She is a native San Franciscan.
Education & training
Board certification
- Certified Genetic Counselor, American Board of Genetic Counseling
Degree
- MS, University of California Berkeley
Locations
Component Name: Provider Research Listing component built but no clinical trials or publications to display
Clinical Trials query: q=health_gateway_id_ss%3A%28%221515%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%221515%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.